Westfield Capital Management CO LP Horizon Therapeutics Public LTD CO Transaction History

Westfield Capital Management CO LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$79.4 - $116.36 $6.68 Million - $9.79 Million	84,113 Added 9.24%	993,942 $79.3 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $17.1 Million - $21.7 Million	198,015 Added 27.82%	909,829 $95.7 Million
Q4 2021 Feb 10, 2022	BUY	$98.56 - $119.91 $70.2 Million - $85.4 Million	711,814 New	711,814 $76.7 Million
Q3 2021 Nov 12, 2021	SELL	$91.91 - $110.37 $26.9 Million - $32.3 Million	-293,016 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$86.24 - $95.92 $30.8 Million - $34.2 Million	-357,048 Reduced 54.93%	293,016 $27.4 Million
Q1 2021 May 14, 2021	SELL	$71.83 - $95.48 $11.2 Million - $14.9 Million	-156,124 Reduced 19.37%	650,064 $59.8 Million
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $54 Million - $68 Million	806,188 New	806,188 $59 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.